Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Teva Could Market Generic Lipitor by Month’s End, Calcalist Says

Nov. 3 (Bloomberg) -- Teva Pharmaceutical Industries Ltd. could begin marketing a generic version of Lipitor by the end of the month through a partnership with India’s Ranbaxy Laboratories Ltd., Calcalist reported today, without saying how it obtained the information..

A message left on the answering machine of a Teva spokesman before office hours was not immediately answered.

Click here for web link

Link to Company News:{PFE US <Equity> CN <GO>} Link to Company News:{RBXY IN <Equity> CN <GO>} Link to Company News:{TEVA IT <Equity> CN <GO>}

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Calev Ben-David at cbendavid@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.